Details

Autor(en) / Beteiligte

• Kinoshita, Makoto
• Yokote, Koutaro
• Arai, Hidenori
• Iida, Mami
• Ishigaki, Yasushi
• Ishibashi, Shun
• Umemoto, Seiji
• Egusa, Genshi
• Ohmura, Hirotoshi
• Okamura, Tomonori
• Kihara, Shinji
• Koba, Shinji
• Saito, Isao
• Shoji, Tetsuo
• Daida, Hiroyuki
• Tsukamoto, Kazuhisa
• Deguchi, Juno
• Dohi, Seitaro
• Dobashi, Kazushige
• Hamaguchi, Hirotoshi
• Hara, Masumi
• Hiro, Takafumi
• Biro, Sadatoshi
• Fujioka, Yoshio
• Maruyama, Chizuko
• Miyamoto, Yoshihiro
• Murakami, Yoshitaka
• Yokode, Masayuki
• Yoshida, Hiroshi
• Rakugi, Hiromi
• Wakatsuki, Akihiko
• Yamashita, Shizuya
• Committee for Epidemiology and Clinical Management of Atherosclerosis

Titel

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Ist Teil von

• Journal of Atherosclerosis and Thrombosis, 2018/09/01, Vol.25(9), pp.846-984

Ort / Verlag

Japan: Japan Atherosclerosis Society

Erscheinungsjahr

2018

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• [Preamble] Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS has included objectives that consider all the risk factors for atherosclerotic cardiovascular diseases (ASCVD) and has accordingly been publishing manuals, such as the "Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases." Because guidelines should be based on evidence of diagnoses and treatments that have already been validated, regular revisions are necessary to administer medical care of high quality. Apart from age, gender, and family history, for which clinical intervention is not possible, the major risk factors for ASCVD include diabetes, hypertension, smoking, and dyslipidemia. Dyslipidemia is a huge risk factor for coronary artery disease (CAD), a form of ASCVD, and in the current set of guidelines, we will be dealing with CAD as the main disease of interest. Nevertheless, other risk factors also ought to be thoroughly managed as part of the efforts for preventing ASCVD. In 1987, a consensus conference on hyperlipidemia was held at the JAS, and reference values for diagnosing hyperlipidemia were proposed.